NASDAQ: APVO - Aptevo Therapeutics Inc.

Yield per half year: -76.79%
Dividend yield: 0.00%
Sector: Healthcare

Aptevo Therapeutics Inc.

160.0000160.0000120.0000120.000080.000080.000040.000040.00000.00000.0000May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
0.2476 57.09 -99.57% -2.08 -111.87%
P/S 3.39 33.5 -89.87%
P/BV 0.2865 4.61 -93.79%
P/FCF -0.1976 39.66 -100.5%
Ev/Ebitda 0.1107 -19.46 -100.57%
Ev/S -0.8783 22.56 -103.89%
Ev/FCF 0.1145 45.47 -99.75%
E/P -5.13 0.0172 -29843.67%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-793.61 -14.42 5403.29% -530.46 +49.61%
ROE -284.28 9.01 -3255.06%
ROA -119.36 0.0151 -788215.05%
ROIC -211.02 7.63 -2864.08%
ROS -778.39 -26.5 2836.8%
ROCE -607.32 13.75 -4515.93%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.1882 -3.73 -94.95% -0.2774 -32.17%
Nеt Debt/Ebitda 0.166 -3.19 -105.2%
Debt/Ratio 0.2969 0.1777 67.06%
Debt/Equity 0.1683 1.57 -89.29%
Debt/Net Income -0.1918 0.8429 -122.76%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5467 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2387 -100%
Average dividend growth 0 1.55 -100%
Average percentage for 5 years 0 0.4967 -100%
Average percentage for payments 0.0094 43.73 -99.98%
Difference from average difference in sector -0.5467

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-78.75 73.67 -206.9%
Growth impulse Ebitda in 5 years 50.53 15.28 230.69%
Growth impulse Net Income in 5 years 34.06 -33.08 -202.96%
Growth impulse FCF in 5 years -17.98 -6.99 157.22%
Growth impulse EPS in 5 years 1518.87 -59.11 -2669.57%
IP Score
4.26/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription